Park Medi World IPO Allotment Date Steps To Check Status, Latest GMP And Listing Date

5 days ago 5
ARTICLE AD BOX

The initial public offering (IPO) of Park Medi World Ltd. witnessed strong investor demand, being oversubscribed 8.10 times on the final day of bidding. A total of 4,18,18,182 shares were offered, while bids reached 33,88,29,652, highlighting robust market interest.

The Qualified Institutional Buyers (QIBs) booked the issue 11.48 times. The Non-Institutional Investors’ (NIIs) category was subscribed 15.15 times. Retail investors booked their quota 3.16 times. 

The IPO opened for subscription on Dec. 10 and closed on Dec. 12. Following the IPO allotment, the shares will list on BSE and NSE, with a tentative listing date of Dec. 17.

Following the successful closure of the subscription window, investors are now waiting for the allotment of the shares. The company is scheduled to finalise the IPO allotment status on Monday, Dec. 15.

Park Medi World IPO was a book-built issue of Rs 920 crores, including a fresh issue of 4.75 crore shares worth Rs 770 crores and an offer-for-sale (OFS) of 93 lakh shares worth Rs 150 crore. 

Incorporated in 2011, Park Medi World Ltd. is a private hospital chain in northern India.

Investors who applied for the IPO can check their allotment status on the official websites of the NSE, BSE and the issue registrar, KFin Technologies Ltd.

Park Medi World IPO Subscribed 8.10 Times On Day Three; GMP Suggests Modest Listing Gains

Steps To Check Park Medi World IPO Allotment Status On BSE

Nephrocare Health IPO Allotment: Check Date, GMP, Step-By-Step Guide To Verify Status Online

How To Check Park Medi World IPO Allotment Status On NSE

Steps To Check Park Medi World IPO Allotment On KFin Technologies

According to InvestorGain, the Grey Market Premium (GMP) for Park Medi World IPO was Rs 7, as of Dec. 14. With a price band cap of Rs 162, the estimated listing price is Rs 169 (cap price plus GMP). It indicates an expected gain of approximately 4.32% per share on listing.

Note: GMP is not an official source of data and is based on speculation.

Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read the red herring prospectus thoroughly before placing bids.

Read Entire Article